Key takeaways
- • Severity: No clinically significant interaction known.
- • Wegovy (weight management (FDA-approved obesity)) and Metformin (Glucophage) (Biguanide (diabetes)).
- • Clinical management: Routinely continued together; no dose adjustment required for the interaction itself. The prescriber will decide overall diabetes regimen.
- • Monitoring: No specific monitoring beyond standard diabetes follow-up (A1c, renal function).
Mechanism
Metformin is not significantly affected by delayed gastric emptying because it is dosed at steady state and has a wide therapeutic window. Semaglutide has not been shown to meaningfully alter metformin pharmacokinetics in clinical interaction studies. The combination is one of the most studied and routinely co-prescribed regimens in type 2 diabetes.
Clinical management
Routinely continued together; no dose adjustment required for the interaction itself. The prescriber will decide overall diabetes regimen.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Wegovy or Metformin (Glucophage).
Monitoring
No specific monitoring beyond standard diabetes follow-up (A1c, renal function).
Source / FDA label citation
Ozempic/Wegovy USPI Drug Interactions section addresses oral medication absorption generally; no specific metformin restriction.
Editorial confidence: 9/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Metformin (Glucophage) with Wegovy?
Metformin (Glucophage) and Wegovy have no clinically significant interaction documented. Standard prescribing applies. Always confirm with your prescriber, since individual medical history can change the calculation.
What's the mechanism of any Wegovy + Metformin (Glucophage) interaction?
Metformin is not significantly affected by delayed gastric emptying because it is dosed at steady state and has a wide therapeutic window. Semaglutide has not been shown to meaningfully alter metformin pharmacokinetics in clinical interaction studies. The combination is one of the most studied and routinely co-prescribed regimens in type 2 diabetes.
What should I monitor when on Wegovy + Metformin (Glucophage)?
No specific monitoring beyond standard diabetes follow-up (A1c, renal function).
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.